Long-term safety and efficacy of the sodium-glucose cotransporter 2 inhibitor, tofogliflozin, added on glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: a 52-week open-label, multicenter, post-marketing clinical study
Exercise is associated with slowed or reduced weight gain
Supports better sleep and recovery
Thereafter, this subsequent treatment episode with the incretin-based drug of interest was eligible for inclusion, with the date of filling the prescription constituting start of the treatment episode
Another myth is that more is automatically better
(2020) BPC-157 and tendon fibroblast healing mechanisms TB-500 Studied for cell migration and cytoskeletal dynamics Interacts with actin regulation pathways Commonly referenced in wound healing models Resources & Research Studies TB-500 Goldstein et al